310 related articles for article (PubMed ID: 22075195)
1. Serologic laboratory findings in malignancy.
Madrid FF; Maroun MC
Rheum Dis Clin North Am; 2011 Nov; 37(4):507-25. PubMed ID: 22075195
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromes.
Solans-Laqué R; Pérez-Bocanegra C; Salud-Salvia A; Fonollosa-Plá V; Rodrigo MJ; Armadans L; Simeón-Aznar CP; Vilardell-Tarres M
Lupus; 2004; 13(3):159-64. PubMed ID: 15119543
[TBL] [Abstract][Full Text] [Related]
3. Association of Anti-Transcription Intermediary Factor 1γ Antibodies With Paraneoplastic Rheumatic Syndromes Other Than Dermatomyositis.
Venalis P; Selickaja S; Lundberg K; Rugiene R; Lundberg IE
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):648-651. PubMed ID: 28704599
[TBL] [Abstract][Full Text] [Related]
4. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies.
Abu-Shakra M; Buskila D; Ehrenfeld M; Conrad K; Shoenfeld Y
Ann Rheum Dis; 2001 May; 60(5):433-41. PubMed ID: 11302861
[TBL] [Abstract][Full Text] [Related]
5. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.
Madrid FF; Maroun MC; Olivero OA; Long M; Stark A; Grossman LI; Binder W; Dong J; Burke M; Nathanson SD; Zarbo R; Chitale D; Zeballos-Chávez R; Peebles C
BMC Cancer; 2015 May; 15():407. PubMed ID: 25975273
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
Fernández Madrid F
Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
[TBL] [Abstract][Full Text] [Related]
8. Serum autoantibodies as biomarkers for early cancer detection.
Tan HT; Low J; Lim SG; Chung MC
FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic anti-neuronal nuclear IgG autoantibodies (type I) localize antigen in small cell lung carcinoma.
Kiers L; Altermatt HJ; Lennon VA
Mayo Clin Proc; 1991 Dec; 66(12):1209-16. PubMed ID: 1660950
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.
Liu W; Wang P; Li Z; Xu W; Dai L; Wang K; Zhang J
Scand J Immunol; 2009 Jan; 69(1):57-63. PubMed ID: 19140877
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer.
Shi L; Chevolot Y; Souteyrand E; Laurenceau E
Cancer Biomark; 2017; 18(2):105-116. PubMed ID: 27983529
[TBL] [Abstract][Full Text] [Related]
12. Serologic autoantibodies as diagnostic cancer biomarkers--a review.
Zaenker P; Ziman MR
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2161-81. PubMed ID: 24057574
[TBL] [Abstract][Full Text] [Related]
13. Usage of cancer associated autoantibodies in the detection of disease.
Dudas SP; Chatterjee M; Tainsky MA
Cancer Biomark; 2010; 6(5-6):257-70. PubMed ID: 20938086
[TBL] [Abstract][Full Text] [Related]
14. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies for cancer detection: still cause for excitement?
Nolen BM; Lokshin AE
Cancer Biomark; 2010; 6(5-6):229-45. PubMed ID: 20938084
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in breast cancer.
Fernández-Madrid F; Maroun MC
Adv Clin Chem; 2014; 64():221-40. PubMed ID: 24938020
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.
Heo CK; Bahk YY; Cho EW
BMB Rep; 2012 Dec; 45(12):677-85. PubMed ID: 23261052
[TBL] [Abstract][Full Text] [Related]
19. Protein arrays as tools for serum autoantibody marker discovery in cancer.
Kijanka G; Murphy D
J Proteomics; 2009 Aug; 72(6):936-44. PubMed ID: 19258055
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against aberrant glycans as cancer biomarkers.
Blsakova A; Kveton F; Kasak P; Tkac J
Expert Rev Mol Diagn; 2019 Dec; 19(12):1057-1068. PubMed ID: 31665948
[No Abstract] [Full Text] [Related]
[Next] [New Search]